Watch on Demand: Managing and Treating Leukemia and Other Blood Cancers | MyMyelomaTeam

Connect with others who understand.

sign up log in
Resources
About MyMyelomaTeam
Powered By

Watch on Demand: Managing and Treating Leukemia and Other Blood Cancers

Written by Torrey Kim
Updated on September 27, 2021
View reactions

“Fatigue can be very difficult to fix — but having said that, one of the things we do when we're assessing folks with blood cancer is try to see if there are, in fact, reversible causes of fatigue.”

Dr. Matt Kalaycio shared this important insight during MyMyelomaTeam’s latest Q&A session, when members of the myeloma community had a chance to learn more about managing and treating blood cancers.

Dr. Kalaycio joined MyMyelomaTeam’s Heather Lapidus Glassner to answer questions on how to manage fatigue, whether cardiac conditions can occur alongside blood cancers, and how someone would know whether they’re a candidate for a stem cell transplant.

Check out the video for a few more topics Dr. Kalaycio discussed during the Q&A session:

  • Whether people with blood cancer should get vaccinated against COVID-19
  • How to handle mental health symptoms when living with blood cancer
  • Tips for talking to your oncologist via telehealth

Watch the video to see the entire one-hour event, and register to be notified about upcoming Q&A sessions on MyMyelomaTeam.

Disclaimer: The information, including but not limited to, information from presenters, text, graphics, images, and other material shared during this event is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you heard during this event.

Speakers:

Dr. Matt Kalaycio is a board-certified hematologist and a professor in the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. Dr. Kalaycio sits on the board of directors for the National Comprehensive Cancer Network (NCCN). His clinical interests include leukemia and hematopoietic cell transplantation, and he has published more than 200 research articles in scientific journals. Dr. Kalaycio is a former chairman of the department of hematology and medical oncology at the Taussig Cancer Institute at Cleveland Clinic, and he previously served as editor-in-chief of Hematology News. Dr. Kalaycio is a fellow of the American College of Physicians.

Heather Lapidus Glassner has over two decades of experience in market research. She has been with MyHealthTeam for six years, conducting social listening and quantitative survey research. Her focus is to raise awareness of life with chronic conditions, including leukemia, multiple sclerosis, lupus, Parkinson’s disease, COPD, Crohn’s disease and ulcerative colitis, migraine, and psoriasis. Heather's work has been presented at the Consortium of Multiple Sclerosis Centers and the International Congress on Systemic Lupus Erythematosus.

Updated on September 27, 2021
View reactions
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest articles about myeloma sent to your inbox.

Torrey Kim is a freelance writer with MyHealthTeam. Learn more about her here.

Related articles

“I’m starting a new treatment next week,” wrote a member of MyMyelomaTeam. “I’m hoping for good r...

Participating in Clinical Trials for Multiple Myeloma: 4 Possible Benefits and 3 Risks

“I’m starting a new treatment next week,” wrote a member of MyMyelomaTeam. “I’m hoping for good r...
This is a short guided meditation by Dr. Christiane Wolf on self-kindness, which gives you more s...

Self-Kindness When Struggling: 6-Minute Guided Meditation

This is a short guided meditation by Dr. Christiane Wolf on self-kindness, which gives you more s...
Most people ask more questions when ordering a meal at a restaurant or purchasing a cellphone tha...

36 Questions About Cancer and Myeloma To Ask Your Doctor

Most people ask more questions when ordering a meal at a restaurant or purchasing a cellphone tha...
The U.S. Food and Drug Administration (FDA) has approved updated boosters for messenger RNA (mRN...

New COVID-19 Vaccine Boosters for Omicron: What To Know if You Have Myeloma

The U.S. Food and Drug Administration (FDA) has approved updated boosters for messenger RNA (mRN...
If you’ve received a myeloma diagnosis, you may be wondering how alcohol consumption can affect y...

Myeloma and Alcohol: 4 Things To Know

If you’ve received a myeloma diagnosis, you may be wondering how alcohol consumption can affect y...
Working while undergoing treatment for multiple myeloma is a personal decision with several fac...

Working With Multiple Myeloma

Working while undergoing treatment for multiple myeloma is a personal decision with several fac...

Recent articles

Telling the difference between Waldenström’s macroglobulinemia (WM) and multiple myeloma is a lit...

Waldenström’s Macroglobulinemia vs. Multiple Myeloma: 4 Differences

Telling the difference between Waldenström’s macroglobulinemia (WM) and multiple myeloma is a lit...
If you or a loved one is living with multiple myeloma, you might worry about the cancer spreading...

Can Multiple Myeloma Affect the Brain?

If you or a loved one is living with multiple myeloma, you might worry about the cancer spreading...
When you’re first diagnosed with multiple myeloma, your doctor will prescribe first-line treatmen...

Refractory Myeloma: 6 Treatment Options

When you’re first diagnosed with multiple myeloma, your doctor will prescribe first-line treatmen...
Maintenance therapy for multiple myeloma consists of ongoing treatment that starts after a stem c...

6 Facts About Myeloma Maintenance Therapy

Maintenance therapy for multiple myeloma consists of ongoing treatment that starts after a stem c...
After you receive a multiple myeloma diagnosis, first-line therapies are used to control the canc...

What Is the Relapse Rate for Multiple Myeloma? 9 Treatment Options After Relapse

After you receive a multiple myeloma diagnosis, first-line therapies are used to control the canc...
Relapsed/refractory multiple myeloma (RRMM) is an aggressive form of myeloma that can be hard to ...

Relapsed/Refractory Multiple Myeloma: What To Know

Relapsed/refractory multiple myeloma (RRMM) is an aggressive form of myeloma that can be hard to ...
MyMyelomaTeam My myeloma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close